219 related articles for article (PubMed ID: 29661606)
1. Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei.
Sharifzadeh A; Khosravi AR; Shokri H; Shirzadi H
J Mycol Med; 2018 Jun; 28(2):294-299. PubMed ID: 29661606
[TBL] [Abstract][Full Text] [Related]
2. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
Shokri H; Sharifzadeh A
J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
[TBL] [Abstract][Full Text] [Related]
3. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
4. The Inhibitory Effect of Human Beta-defensin-3 on
Inthanachai T; Thammahong A; Edwards SW; Virakul S; Kiatsurayanon C; Chiewchengchol D
Immunol Invest; 2021 Jan; 50(1):80-91. PubMed ID: 32316784
[No Abstract] [Full Text] [Related]
5. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system.
Moazeni M; Kelidari HR; Saeedi M; Morteza-Semnani K; Nabili M; Gohar AA; Akbari J; Lotfali E; Nokhodchi A
Colloids Surf B Biointerfaces; 2016 Jun; 142():400-407. PubMed ID: 26974361
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Huanglian Jiedu decoction in combination with fluconazole on ergosterol of fluconazole-resistant Candida albicans].
Yan YY; Wang TM; Shi GX; Zhang MX; Lu KQ; Shao J; Wang CZ
Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):727-32. PubMed ID: 26137698
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans.
Guo N; Liu J; Wu X; Bi X; Meng R; Wang X; Xiang H; Deng X; Yu L
J Med Microbiol; 2009 Aug; 58(Pt 8):1074-1079. PubMed ID: 19528168
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
9. Reversal of fluconazole resistance induced by a synergistic effect with Acca sellowiana in Candida glabrata strains.
R M Machado GD; Pippi B; Dalla Lana DF; Amaral AP; Teixeira ML; Souza KC; Fuentefria AM
Pharm Biol; 2016 Nov; 54(11):2410-2419. PubMed ID: 27050162
[TBL] [Abstract][Full Text] [Related]
10. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic
Kane A; Dinh H; Campbell L; Cain AK; Hibbs D; Carter D
Microbiol Spectr; 2024 Jun; 12(6):e0012124. PubMed ID: 38695556
[TBL] [Abstract][Full Text] [Related]
12. In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates.
Moraes RC; Carvalho AR; Lana AJ; Kaiser S; Pippi B; Fuentefria AM; Ortega GG
Pharm Biol; 2017 Dec; 55(1):406-415. PubMed ID: 27931150
[TBL] [Abstract][Full Text] [Related]
13. Effects of antifungal agents alone and in combination against Candida glabrata strains susceptible or resistant to fluconazole.
Alves IA; Bandeira LA; Mario DA; Denardi LB; Neves LV; Santurio JM; Alves SH
Mycopathologia; 2012 Sep; 174(3):215-21. PubMed ID: 22528740
[TBL] [Abstract][Full Text] [Related]
14. Fungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative medium.
Moosa MY; Sobel JD; Elhalis H; Du W; Akins RA
Antimicrob Agents Chemother; 2004 Jan; 48(1):161-7. PubMed ID: 14693534
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan.
Yang YL; Cheng HH; Ho YA; Hsiao CF; Lo HJ
J Microbiol Immunol Infect; 2003 Sep; 36(3):187-91. PubMed ID: 14582563
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints].
Hazırolan G; Sarıbaş Z; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Jul; 50(3):428-37. PubMed ID: 27525398
[TBL] [Abstract][Full Text] [Related]
17. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
González GM; Elizondo M; Ayala J
J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
[TBL] [Abstract][Full Text] [Related]
18. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Posteraro B; Martucci R; La Sorda M; Fiori B; Sanglard D; De Carolis E; Florio AR; Fadda G; Sanguinetti M
J Clin Microbiol; 2009 Jun; 47(6):1927-30. PubMed ID: 19403774
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
[TBL] [Abstract][Full Text] [Related]
20. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
